Order Article Reprints

Vallarola A, Tortarolo M, De Gioia R, Iamele L, de Jonge H, de Nola G, Bovio E, Pasetto L, Bonetto V, Freschi M, et al. A Novel HGF/SF Receptor (MET) Agonist Transiently Delays the Disease Progression in an Amyotrophic Lateral Sclerosis Mouse Model by Promoting Neuronal Survival and Dampening the Immune Dysregulation. International Journal of Molecular Sciences. 2020; 21(22):8542. https://doi.org/10.3390/ijms21228542

Vallarola, Antonio, Massimo Tortarolo, Roberta De Gioia, Luisa Iamele, Hugo de Jonge, Giovanni de Nola, Enrica Bovio, Laura Pasetto, Valentina Bonetto, Mattia Freschi, and et al. 2020. "A Novel HGF/SF Receptor (MET) Agonist Transiently Delays the Disease Progression in an Amyotrophic Lateral Sclerosis Mouse Model by Promoting Neuronal Survival and Dampening the Immune Dysregulation" International Journal of Molecular Sciences 21, no. 22: 8542. https://doi.org/10.3390/ijms21228542

Vallarola, A., Tortarolo, M., De Gioia, R., Iamele, L., de Jonge, H., de Nola, G., Bovio, E., Pasetto, L., Bonetto, V., Freschi, M., Bendotti, C., & Gherardi, E. (2020). A Novel HGF/SF Receptor (MET) Agonist Transiently Delays the Disease Progression in an Amyotrophic Lateral Sclerosis Mouse Model by Promoting Neuronal Survival and Dampening the Immune Dysregulation. International Journal of Molecular Sciences, 21(22), 8542. https://doi.org/10.3390/ijms21228542